Zur Rose Group AG operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zur Rose Group AG with three other
drug stores in Europe:
Udg Healthcare Plc
sales of 1.10 billion Euro [US$1.22 billion]
of which 70%
Dermapharm Holding SE
(572.42 million Euro [US$633.91 million]
of which 58%
was Pharmaceuticals and other products), and
based in Finland
(1.55 billion Euro [US$1.72 billion]
of which 171%
Zur Rose Group AG reported sales of 1.21 billion Swiss Francs (US$1.22 billion)
December of 2018.
increase of 22.8%
versus 2017, when the company's sales were 982.92 million Swiss Francs.
This was the third consecutive year of growth at Zur Rose Group AG.
Sales of Germany saw an increase
38.9% in 2018, from
483.17 million Swiss Francs to 671.25 million Swiss Francs.